• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

4AY:GR

8.325 EUR 0.021 0.25%

As of 09:58:38 ET on 10/02/2014.

Snapshot for Ablynx NV (4AY)

Open: 8.337 Day's Range: 8.325 - 8.354 Volume: 0
Previous Close: 8.346 52wk Range: 6.606 - 10.010 1-Yr Rtn: +6.95%

Stock Chart for 4AY

No chart data available.
  • 4AY:GR 8.354
  • 1D
  • 1M
  • 1Y
8.346
Interactive 4AY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4AY

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) -0.2420
Est. PEG Ratio -
Market Cap (M EUR) 449.56
Shares Outstanding (M) 54.00
30 Day Average Volume 75
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4AY

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for 4AY

Ablynx NV is a biopharmaceutical company. The Company discovers and develops therapeutic protein treatments for human diseases.

Edwin MosesChief Executive OfficerWim OttevaereChief Financial Officer
Josefin-Beate Holz "Josi"Chief Medical OfficerMarieke VermeerschAssociate Dir:Investor Relations
More Company Profile & Key Executives for 4AY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil